Literature DB >> 26857764

Genetics of Cystic Fibrosis: Clinical Implications.

Marie E Egan1.   

Abstract

Cystic fibrosis (CF) is a common life-shortening autosomal recessive genetic disorder caused by mutations in the gene that encodes for the cystic fibrosis transmembrane conductance regulator protein (CFTR). Almost 2000 variants in the CFTR gene have been identified. The mutational classes are based on the functional consequences on CFTR. New therapies are being developed to target mutant CFTR and restore CFTR function. Understanding specific CF genotypes is essential for providing state-of-the art care to patients. In addition to the variation in CFTR genotype, there are several modifier genes that contribute to the respiratory phenotype.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Corrector; Cystic fibrosis transmembrane conductance regulator protein mutation; Genetic modifier; Potentiator; Read through agent

Mesh:

Substances:

Year:  2015        PMID: 26857764     DOI: 10.1016/j.ccm.2015.11.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  13 in total

1.  Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis.

Authors:  Adriana Carolina Marques Ferreira; Fernando Augusto Lima Marson; Milena Antonelli Cohen; Carmen Silvia Bertuzzo; Carlos Emilio Levy; Antonio Fernando Ribeiro; Jose Dirceu Ribeiro
Journal:  Lung       Date:  2017-04-28       Impact factor: 2.584

2.  Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review.

Authors:  Sharon J M Kessels; Drew Carter; Benjamin Ellery; Skye Newton; Tracy L Merlin
Journal:  Genet Med       Date:  2019-08-30       Impact factor: 8.822

Review 3.  Review of Rapid Advances in Cystic Fibrosis.

Authors:  Stephanie L Link; Ravi P Nayak
Journal:  Mo Med       Date:  2020 Nov-Dec

Review 4.  Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease.

Authors:  Camilla Margaroli; Rabindra Tirouvanziam
Journal:  Mol Cell Pediatr       Date:  2016-12-05

Review 5.  Delivering on the promise of gene editing for cystic fibrosis.

Authors:  Craig A Hodges; Ronald A Conlon
Journal:  Genes Dis       Date:  2018-11-25

6.  Genetic and phenotypic traits of children and adolescents with cystic fibrosis in Southern Brazil.

Authors:  Katiana Murieli da Rosa; Eliandra da Silveira de Lima; Camila Correia Machado; Thaiane Rispoli; Victória d'Azevedo Silveira; Renata Ongaratto; Talitha Comaru; Leonardo Araújo Pinto
Journal:  J Bras Pneumol       Date:  2018 Nov-Dec       Impact factor: 2.624

7.  High-resolution computed tomography findings in young infants with cystic fibrosis detected by newborn screening.

Authors:  Renata Wrobel Folescu Cohen; Tânia Wrobel Folescu; Marcia Cristina Bastos Boechat; Vania Matos Fonseca; Elizabeth Andrade Marques; Robson Souza Leão
Journal:  Clinics (Sao Paulo)       Date:  2019-10-21       Impact factor: 2.365

8.  Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools.

Authors:  Stéphanie Villa-Nova Pereira; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Carmen Sílvia Bertuzzo; Fernando Augusto Lima Marson
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

Review 9.  The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections.

Authors:  Daniel J Hassett; Rhett A Kovall; Michael J Schurr; Nalinikanth Kotagiri; Harshita Kumari; Latha Satish
Journal:  Front Microbiol       Date:  2021-06-17       Impact factor: 5.640

10.  Use of a High-Throughput Phenotypic Screening Strategy to Identify Amplifiers, a Novel Pharmacological Class of Small Molecules That Exhibit Functional Synergy with Potentiators and Correctors.

Authors:  Kenneth A Giuliano; Shinichiro Wachi; Lawrence Drew; Danijela Dukovski; Olivia Green; Cecilia Bastos; Matthew D Cullen; Sheila Hauck; Bradley D Tait; Benito Munoz; Po-Shun Lee; John Preston Miller
Journal:  SLAS Discov       Date:  2017-09-12       Impact factor: 3.341

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.